# RiskMitigation: __Evaluation of symptoms__ (PBN__Mitigation_1626)

## Property: has_MitigationTechnology

* [clinical assessment](../Technology/PBN__Technology_3957)

## Property: has_MitigationSource

* [pilz_contributions_2022](../Article/PBN__Article_245)

## Property: has_MitigationPrinciple

Assesses whether the efficacy of protection against re-infections differs in individuals with and without symptoms during their first infection

